InvestorsHub Logo
Followers 3
Posts 132
Boards Moderated 0
Alias Born 06/12/2014

Re: None

Monday, 04/20/2015 5:01:52 PM

Monday, April 20, 2015 5:01:52 PM

Post# of 402741
Is this CTIX at ASCO from the Iplanner...

Abstract #TPS2613

A phase 1, dose-escalation, safety, pharmacokinetic, pharmacodynamic study of thioureidobutyronitrile, a novel p53 targeted therapy, in patients with advanced solid tumors.

Geoffrey Shapiro, MD, PhD

Dana-Farber Cancer Institute


https://iplanner.asco.org/am2015/AM2015.aspx/Search
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News